Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (621-630 of 850) with videos related to

Pageof 85
Sort By:
European Urology Focus|July 28, 2023
Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical ProstatectomyAli Sabbagh, Derya Tilki, Jean Feng, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision MakingPhilipp Mandel, Mike Wenzel, Benedikt Hoeh, et al.
Prostate International|March 9, 2022
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancerBenedikt Hoeh, Rocco Flammia, Lukas Hohenhorst, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Urethral Sphincter Length but Not Prostatic Apex Shape in Preoperative MRI Is Associated with Mid-Term Continence Rates after Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Matthias Müller, et al.
Marine Drugs|March 28, 2023
New Bioactive β-Resorcylic Acid Derivatives from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685Elena V Leshchenko, Alexandr S Antonov, Gleb V Borkunov, et al.
European Urology Focus|December 28, 2020
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate BiopsyMike Wenzel, Maria N Welte, Lena H Theissen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysisMike Wenzel, Marina Deuker, Luigi Nocera, et al.
Nature Communications|December 23, 2025
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancerMigle Mikutenaite, Evdoxia Karadoulama, Francesco Favero, et al.
The Prostate|October 18, 2021
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
International Urology and Nephrology|November 16, 2021
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patientsBenedikt Hoeh, Jan L Hohenhorst, Rocco Flammia, et al.
Pageof 85

Showing results (621-630 of 850) with videos related to

Sort By:
Pageof 85
European Urology Focus|July 28, 2023
Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical ProstatectomyAli Sabbagh, Derya Tilki, Jean Feng, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision MakingPhilipp Mandel, Mike Wenzel, Benedikt Hoeh, et al.
Prostate International|March 9, 2022
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancerBenedikt Hoeh, Rocco Flammia, Lukas Hohenhorst, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Urethral Sphincter Length but Not Prostatic Apex Shape in Preoperative MRI Is Associated with Mid-Term Continence Rates after Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Matthias Müller, et al.
Marine Drugs|March 28, 2023
New Bioactive β-Resorcylic Acid Derivatives from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685Elena V Leshchenko, Alexandr S Antonov, Gleb V Borkunov, et al.
European Urology Focus|December 28, 2020
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate BiopsyMike Wenzel, Maria N Welte, Lena H Theissen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysisMike Wenzel, Marina Deuker, Luigi Nocera, et al.
Nature Communications|December 23, 2025
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancerMigle Mikutenaite, Evdoxia Karadoulama, Francesco Favero, et al.
The Prostate|October 18, 2021
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
International Urology and Nephrology|November 16, 2021
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patientsBenedikt Hoeh, Jan L Hohenhorst, Rocco Flammia, et al.
Pageof 85